CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
9 hedge funds and large institutions have $9.23M invested in Celyad Oncology SA American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
+$110K |
2 |
UBS Group
Zurich,
Switzerland
|
+$5.51K |
Top Sellers
1 |
Victory Capital Management
San Antonio,
Texas
|
-$13M |
2 |
Morgan Stanley
New York
|
-$83K |
3 |
Wells Fargo
San Francisco,
California
|
-$10.6K |
4 |
Millennium Management
New York
|
-$9.36K |
5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4K |